117 related articles for article (PubMed ID: 29197744)
1. Transcriptional landscape of a RET
Hadoux J; Desterke C; Féraud O; Guibert M; De Rose RF; Opolon P; Divers D; Gobbo E; Griscelli F; Schlumberger M; Bennaceur-Griscelli A; Turhan AG
Stem Cell Res; 2018 Jan; 26():8-16. PubMed ID: 29197744
[TBL] [Abstract][Full Text] [Related]
2. Correction of Hirschsprung-Associated Mutations in Human Induced Pluripotent Stem Cells Via Clustered Regularly Interspaced Short Palindromic Repeats/Cas9, Restores Neural Crest Cell Function.
Lai FP; Lau ST; Wong JK; Gui H; Wang RX; Zhou T; Lai WH; Tse HF; Tam PK; Garcia-Barcelo MM; Ngan ES
Gastroenterology; 2017 Jul; 153(1):139-153.e8. PubMed ID: 28342760
[TBL] [Abstract][Full Text] [Related]
3. [The clinical patterns and RET proto-oncogene in fifteen multiple endocrine neoplasia type 2A pedigrees].
Zhou YL; Zhu SX; Li JJ; Liu JB; Yin M; Xiao BY; Yu CL; Wang LM; Gu LQ; Cui B; Ning G; Li XY; Zhao YJ
Zhonghua Nei Ke Za Zhi; 2007 Jun; 46(6):466-70. PubMed ID: 17663821
[TBL] [Abstract][Full Text] [Related]
4. RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B.
Zhou Y; Zhao Y; Cui B; Gu L; Zhu S; Li J; Liu J; Yin M; Zhao T; Yin Z; Yu C; Chen C; Wang L; Xiao B; Hong J; Zhang Y; Tang Z; Wang S; Li X; Ning G
Clin Endocrinol (Oxf); 2007 Oct; 67(4):570-6. PubMed ID: 17573899
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of RET with multiple endocrine neoplasia type 2.
Zhang M; Liu Y; Fu J; Hu Y; Sun Z
J Cancer Res Ther; 2017; 13(5):823-828. PubMed ID: 29237911
[TBL] [Abstract][Full Text] [Related]
6. Impact of the overexpression of the tyrosine kinase receptor RET in the hematopoietic potential of induced pluripotent stem cells (iPSCs).
Marcoux P; Imeri J; Desterke C; Latsis T; Chaker D; Hugues P; Griscelli AB; Turhan AG
Cytotherapy; 2024 Jan; 26(1):63-72. PubMed ID: 37921725
[TBL] [Abstract][Full Text] [Related]
7. Generation of an induced pluripotent stem cell line from a patient with hereditary multiple endocrine neoplasia 2B (MEN2B) syndrome with "highest risk" RET mutation.
Bennaceur-Griscelli A; Hadoux J; Féraud O; Opolon P; Divers D; Gobbo E; Schlumberger M; Griscelli F; Turhan AG
Stem Cell Res; 2017 Aug; 23():154-157. PubMed ID: 28925363
[TBL] [Abstract][Full Text] [Related]
8. Transcriptome analysis in mouse tumors induced by Ret-MEN2/FMTC mutations reveals subtype-specific role in survival and interference with immune surveillance.
Engelmann D; Koczan D; Ricken P; Rimpler U; Pahnke J; Li Z; Pützer BM
Endocr Relat Cancer; 2009 Mar; 16(1):211-24. PubMed ID: 18984779
[TBL] [Abstract][Full Text] [Related]
9. Generation of an induced pluripotent stem cell line from a patient with hereditary multiple endocrine neoplasia 2A (MEN2A) syndrome with RET mutation.
Hadoux J; Féraud O; Griscelli F; Opolon P; Divers D; Gobbo E; Schlumberger M; Bennaceur-Griscelli A; Turhan AG
Stem Cell Res; 2016 Jul; 17(1):154-157. PubMed ID: 27558615
[TBL] [Abstract][Full Text] [Related]
10. [Mutation of the RET proto-oncogene in type 2A multiple endocrine neoplasia Chinese families and the application of pentagastrin stimulation test in diagnosis and follow-up].
Yao B; Liu X; Chen X; Dong TT; Liang H; Weng JP
Zhonghua Nei Ke Za Zhi; 2007 Nov; 46(11):914-8. PubMed ID: 18261274
[TBL] [Abstract][Full Text] [Related]
11. A 6-Base Pair in Frame Germline Deletion in Exon 7 Of RET Leads to Increased RET Phosphorylation, ERK Activation, and MEN2A.
Latteyer S; Klein-Hitpass L; Khandanpour C; Zwanziger D; Poeppel TD; Schmid KW; Führer D; Moeller LC
J Clin Endocrinol Metab; 2016 Mar; 101(3):1016-22. PubMed ID: 26765577
[TBL] [Abstract][Full Text] [Related]
12. [DelD631: a novel mutation of the RET proto-oncogene in multiple endocrine neoplasia type 2A (MEN2A)].
Yao B; Liu X; Dong TT; Chen X; Huang ZM; Weng JP
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):1962-5. PubMed ID: 17923033
[TBL] [Abstract][Full Text] [Related]
13. Multiple endocrine neoplasia type 2A in two families with the familial medullary thyroid carcinoma associated G533C mutation of the RET proto-oncogene.
Peppa M; Boutati E; Kamakari S; Pikounis V; Peros G; Panayiotides IG; Economopoulos T; Raptis SA; Hadjidakis D
Eur J Endocrinol; 2008 Dec; 159(6):767-71. PubMed ID: 18805915
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
[TBL] [Abstract][Full Text] [Related]
15. Exome sequencing reveals mutant genes with low penetrance involved in MEN2A-associated tumorigenesis.
Cai J; Li L; Ye L; Jiang X; Shen L; Gao Z; Fang W; Huang F; Su T; Zhou Y; Wang W; Ning G
Endocr Relat Cancer; 2015 Feb; 22(1):23-33. PubMed ID: 25404689
[TBL] [Abstract][Full Text] [Related]
16. RET proto-oncogene mutations are restricted to codon 634 and 618 in Korean families with multiple endocrine neoplasia 2A.
Chung YJ; Kim HH; Kim HJ; Min YK; Lee MS; Lee MK; Kim KW; Ki CS; Kim JW; Chung JH
Thyroid; 2004 Oct; 14(10):813-8. PubMed ID: 15588376
[TBL] [Abstract][Full Text] [Related]
17. High penetrance of pheochromocytoma associated with the novel C634Y/Y791F double germline mutation in the RET protooncogene.
Toledo RA; Wagner SM; Coutinho FL; Lourenço DM; Azevedo JA; Longuini VC; Reis MT; Siqueira SA; Lucon AM; Tavares MR; Fragoso MC; Pereira AA; Dahia PL; Mulligan LM; Toledo SP
J Clin Endocrinol Metab; 2010 Mar; 95(3):1318-27. PubMed ID: 20080836
[TBL] [Abstract][Full Text] [Related]
18. Modeling RET-Rearranged Non-Small Cell Lung Cancer (NSCLC): Generation of Lung Progenitor Cells (LPCs) from Patient-Derived Induced Pluripotent Stem Cells (iPSCs).
Marcoux P; Hwang JW; Desterke C; Imeri J; Bennaceur-Griscelli A; Turhan AG
Cells; 2023 Dec; 12(24):. PubMed ID: 38132167
[TBL] [Abstract][Full Text] [Related]
19. CRISPR correction of the PRKAG2 gene mutation in the patient's induced pluripotent stem cell-derived cardiomyocytes eliminates electrophysiological and structural abnormalities.
Ben Jehuda R; Eisen B; Shemer Y; Mekies LN; Szantai A; Reiter I; Cui H; Guan K; Haron-Khun S; Freimark D; Sperling SR; Gherghiceanu M; Arad M; Binah O
Heart Rhythm; 2018 Feb; 15(2):267-276. PubMed ID: 28917552
[TBL] [Abstract][Full Text] [Related]
20. RET Cys634Arg mutation confers a more aggressive multiple endocrine neoplasia type 2A phenotype than Cys634Tyr mutation.
Valdés N; Navarro E; Mesa J; Casterás A; Alcázar V; Lamas C; Tébar J; Castaño L; Gaztambide S; Forga L
Eur J Endocrinol; 2015 Mar; 172(3):301-7. PubMed ID: 25515555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
